Canephron comprimidos recubiertos
Como usar Canephron comprimidos recubiertos
Introduction
PROSPECTO: INFORMATION FOR THE USER
Canephron Coated Tablets
Lesser Centaury, Levisticum and Rosemary
Read this prospect carefully before starting to take this medicine, because it contains important information for you.
|
1. What is Canephron and what is it used for
Traditional medication based on plants used as an adjunct in the relief of symptoms associated with minor lower urinary tract infections and to increase urine elimination and facilitate the elimination of sand, based exclusively on its traditional use.
Consult a doctor if it worsens or does not improve after 4 days.
2. Before taking Canephron
Do not take Canephron
- If you are allergic to centaury, lemongrass, rosemary, or any of the other components of this medication (listed in section 6).
- If you have been advised to reduce your fluid intake (such as in the case of heart or kidney disease).
- If you have an active peptic ulcer.
- If you have nephritis or any other disease that reduces kidney function.
- In case of edema due to reduced kidney or cardiac function.
Warnings and precautions
Consult your doctor or pharmacist before starting to take Canephron
- If urinary tract discomfort worsens or during use of the product symptoms such as fever, dysuria, spasms, or hematuria appear, you should consult your doctor immediately.
Children and adolescents
Children and adolescents under 18 years should not use this medication.
Warning for diabetic patients
One tablet of this medication contains approximately 0.020 units of carbohydrate exchange units (CEU).
Other medications and Canephron
Inform your doctor or pharmacist if you are using, have used recently, or may need to use other medications.
Taking Canephron with food and drinks
Foods and drinks have no influence on the effect of the medication.
Pregnancy and breastfeeding
If you are pregnant or breastfeeding, think you may be pregnant, or intend to become pregnant, consult your doctor or pharmacist before using this medication.
No adequate and well-controlled studies have been conducted in pregnant women or in breastfeeding women with this medication, so its administration is not recommended in these cases.
Driving and operating machines
No effects have been registered on the ability to drive and operate machines.
Canephron contains lactose monohydrate, glucose syrup, and saccharose
If your doctor has indicated that you have an intolerance to certain sugars, consult with them before taking this medication.
3. How to Take Canephron
Follow exactly the medication administration instructions contained in this leaflet or those indicated by your doctor or pharmacist. If in doubt, ask your doctor or pharmacist.
The recommended dose is:
Adults: Take 2 coated tablets, three times a day.
This medication is administered orally.
The recommended treatment period is 2 weeks, however, if symptoms do not improve after 4 days of treatment, consult your doctor if you should continue with the same.
It is recommended to take the tablets whole, without chewing, with a glass of water or other liquid. (See section “Possible adverse effects”).
Drinking more than 1 liter of water favors treatment.
Use in children and adolescents
Do not use in children and adolescents under 18 years old.
Consult your doctor or pharmacist if you consider that the effects of Canephron are too strong or too weak.
If you take more Canephron than you should
No cases of overdose with Canephron have been reported.
In case of overdose or accidental ingestion, consult your pharmacist or doctor immediately or call the Toxicological Information Service, phone 91.562.04.20, indicating the product and the amount ingested.
If you forgot to take Canephron
Do not take a double dose to compensate for the missed doses.
4. Possible Adverse Effects
Like all medications, Canephron may produce adverse effects, although not all people will experience them.
Very rare cases of gastrointestinal discomfort such as nausea, vomiting, and diarrhea (may affect up to 1 in 10,000 people) have been reported.
In very rare cases (may affect up to 1 in 10,000 people), some allergic reactions (for example, itching, rash, and urticaria) have been described.
If you experience the first signs of an allergic reaction, do not continue taking Canephron.
If you consider any of the adverse effects you are experiencing to be severe or if you notice any adverse effect not mentioned in this prospectus, inform your doctor.
Reporting Adverse Effects
If you experience any type of adverse effect, consult your doctor or pharmacist, even if it is a possible adverse effect not listed in this prospectus. You can also report them directly through the Spanish System for Pharmacovigilance of Medicinal Products for Human Use: www.notificaRAM.es. By reporting adverse effects, you can contribute to providing more information about the safety of this medication.
5. Canephron Storage
Keep out of sight and reach of children.
Do not store at a temperature above 86°F (30°C).
Expiration Date
Do not use this medication after the expiration date that appears on the packaging after CAD. The expiration date is the last day of the month indicated.
Medicines should not be disposed of through drains or in the trash. Dispose of packaging and unused medicines at the SIGRE collection point at the pharmacy. If in doubt, ask your pharmacist how to dispose of unused packaging and medicines. By doing so, you will help protect the environment.
6. Contents of the packaging and additional information
Composition of Canephron:
The active principles are: 18 mg of dried aerial parts of Lesser Centaury (Centaurium erythraeaRafn); 18 mg of dried rhizomes of Lovage (Levisticum officinaleKoch); 18 mg of dried leaves of Rosemary (Rosmarinus officinalisL.).
The other components (excipients) are: lactose monohydrate (45 mg), glucose syrup (1,086 mg), sucrose (60,431 mg), calcium carbonate, magnesium stearate, cornstarch, dextrin, glycomontan wax, virgin castor oil, povidone (25, 30), shellac lacquer, silicon dioxide, talc, iron(III) oxide (E 172), riboflavin (E 101), titanium dioxide (E 171).
Appearance of the product and contents of the packaging
Orange-colored tablets. Packaging with 60, 120, and 200 coated tablets.
Holder of the marketing authorization and Responsible for manufacturing
BIONORICA SE
Kerschensteinerstrasse 11-15
92318 Neumarkt
Germany
Phone +49 / 9181 / 231-90
Fax +49 / 9181 / 231-265
This leaflet was approved in: October 2011
The detailed and updated information on this medication is available on the website of the Spanish Agency of Medicines and Medical Devices (AEMPS) http://www.aemps.es/
- País de registo
- Substância ativa
- Requer receita médicaNão
- Fabricante
- ComposiçãoLactosa monohidrato (45,0 mg mg), Jarabe de glucosa (1,086 mg mg), Sacarosa (60,431 mg mg)
- Esta informação é apenas para referência e não constitui aconselhamento médico. Consulte sempre um médico antes de tomar qualquer medicamento. A Oladoctor não se responsabiliza por decisões médicas baseadas neste conteúdo.
Consulte um médico online sobre o Canephron comprimidos recubiertos
Consulte um médico online
Tem perguntas sobre este medicamento ou sintomas? Obtenha orientação de um médico qualificado, de forma prática e segura.
Receba novidades da plataforma e promoções exclusivas
Fique a par das atualizações da Oladoctor e receba promoções exclusivas para subscritores.
